Loading
Elevate Now
Elevate Now is India's first legally approved medical weight loss and wellness platform, focusing on non-surgical, science-backed solutions for sustainable weight management. The company integrates advanced medical science with personalized care, offering safe access to GLP-1 medications like Semaglutide and Liraglutide under expert medical supervision. The platform provides a fully integrated program that includes FDA-approved medical treatments, at-home diagnostics through NABL-accredited labs, tailored diet plans, and dedicated health coaching. Elevate Now's approach is designed to help individuals achieve a 15–18% reduction in body weight within six months, emphasizing holistic, medically guided weight management. The company serves individuals seeking effective solutions for stubborn weight, particularly those with metabolic conditions or other underlying health issues.
Funding
Every round, secondary, debt facility or acquisition involving Elevate Now that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.
See plans →Log inKey numbers
—
0
—
$9M